Time
Days to earnings18
Next print2026-11-05
WindowBMO
Fiscal2026-09-30
| Date | DTE | Next | Close | Cons. EPS | IV front % | Implied | Ret 5d | Ret 10d | Ret 20d | Ret 30d | EPS high / low | Dispersion | Analysts | P/C | Peers rpt | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-10-12 | 18 | 2026-11-05 | 213.74 | -1.274 | 90.3% | 23.1% | +5.2% | +8.3% | +45.7% | +54.9% | -0.53 / -3.32 | 219.1% | 15 | 1.36 | 0 | |
| 2026-10-09 | 19 | 2026-11-05 | 225.00 | -1.275 | 90.8% | 24.7% | +18.4% | +13.1% | +56.3% | +57.6% | -0.53 / -3.32 | 218.9% | 15 | 1.33 | 0 | |
| 2026-10-08 | 20 | 2026-11-05 | 197.00 | -1.275 | 80.5% | 22.3% | +4.3% | +1.1% | +44.2% | +31.6% | -0.53 / -3.32 | 218.9% | 15 | 1.32 | 0 | |
| 2026-10-07 | 21 | 2026-11-05 | 196.48 | -1.275 | 84.4% | 23.8% | +2.0% | +7.9% | +44.9% | +23.7% | -0.53 / -3.32 | 218.9% | 15 | 1.32 | 0 | |
| 2026-10-06 | 22 | 2026-11-05 | 187.46 | -1.275 | 79.0% | 22.7% | -7.9% | +2.7% | +33.6% | +35.0% | -0.53 / -3.32 | 218.9% | 15 | 1.33 | 0 | |
| 2026-10-05 | 23 | 2026-11-05 | 203.21 | -1.275 | 75.6% | 22.0% | +3.0% | +17.5% | +39.6% | +40.0% | -0.53 / -3.32 | 218.9% | 15 | 1.29 | 0 | |
| 2026-10-02 | 24 | 2026-11-05 | 190.01 | -1.289 | 75.6% | 23.1% | -4.5% | +23.4% | +27.6% | +42.5% | -0.53 / -3.32 | 216.4% | 14 | 1.32 | 0 | |
| 2026-10-01 | 25 | 2026-11-05 | 188.94 | -1.289 | 77.1% | 23.9% | -3.0% | +19.5% | +25.3% | +8.3% | -0.53 / -3.32 | 216.4% | 14 | 1.31 | 0 | |
| 2026-09-30 | 26 | 2026-11-05 | 192.57 | -1.289 | 77.6% | 24.4% | +5.7% | +32.2% | +24.8% | +205.9% | -0.53 / -3.32 | 216.4% | 14 | 1.31 | 0 | |
| 2026-09-29 | 27 | 2026-11-05 | 203.46 | -1.289 | 78.1% | 24.9% | +11.4% | +41.5% | +45.0% | +215.6% | -0.53 / -3.32 | 216.4% | 14 | 1.29 | 0 |
Linked names and their last print
| Peer | Name | Score | Last qtr | Last surprise | Reaction | 1-day close | DTE (full) |
|---|---|---|---|---|---|---|---|
| VRTX primary | Vertex Pharmaceuticals Inc | 0.36 | 2026Q2 · 2026-08-03 | +1.2% | +0.1% | 478.71 | 15 · 2026-10-12 |
| REGN primary | Regeneron Pharmaceuticals Inc | 0.28 | 2026Q2 · 2026-07-30 | +56.6% | +0.9% | 738.34 | 14 · 2026-10-12 |
| PFE primary | Pfizer Inc | 0.25 | 2026Q2 · 2026-08-04 | +13.2% | +0.0% | 25.41 | 16 · 2026-10-12 |
| MRK primary | Merck & Company Inc | 0.25 | 2026Q2 · 2026-08-04 | +50.0% | +0.5% | 128.00 | 13 · 2026-10-12 |
| Fiscal qtr | Report date | Window | Actual EPS | Surprise % | Beat | Reaction | 1-day result | Vol ×10d | Post 10d | Review |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 2026-07-31 | BMO | -1.97 | 0.0% | — | -0.1% | -5.2% | 1.68× | +15.5% | Review |
| 2026Q1 | 2026-05-01 | BMO | -3.40 | -61.1% | Miss | +1.5% | -2.7% | 1.74× | +8.1% | Review |
| 2025Q4 | 2026-02-13 | BMO | -2.11 | +20.1% | Beat | +4.3% | +0.9% | 1.56× | +25.1% | Review |
| 2025Q3 | 2025-11-06 | BMO | -0.51 | +76.4% | Beat | +7.1% | -3.6% | 1.24× | -8.1% | Review |
| 2025Q2 | 2025-08-01 | BMO | -2.13 | +29.0% | Beat | -6.7% | +0.1% | 2.02× | +1.5% | Review |
| 2025Q1 | 2025-05-01 | BMO | -2.52 | +19.0% | Beat | -3.0% | -2.3% | 2.34× | -12.5% | Review |
| 2024Q4 | 2025-02-14 | BMO | -2.91 | -5.4% | Miss | -4.4% | +8.1% | 2.20× | -8.2% | Review |
| 2024Q3 | 2024-11-07 | BMO | 0.03 | +101.6% | Beat | +9.2% | -11.2% | 3.49× | -23.9% | Review |
| 2024Q2 | 2024-08-01 | BMO | -3.33 | +0.6% | Beat | -16.5% | -5.4% | 7.91× | -8.0% | Review |
| 2024Q1 | 2024-05-02 | BMO | -3.07 | +14.0% | Beat | +3.1% | +9.3% | 4.25× | +5.6% | Review |